<DOC>
	<DOCNO>NCT02964702</DOCNO>
	<brief_summary>To evaluate efficacy safety catheter-based thrombectomy reperfusion remove thrombus cerebral blood vessel patient acute cerebral infarction ( within 8 hour onset ) , intravenous administration tissue plasminogen activator ( t-PA ) indicate reperfusion achieve intravenous t-PA administration .</brief_summary>
	<brief_title>Thrombectomy Revascularization Intracranial Vessel OcclusioN Originating From Japan ( TRON1-Japan )</brief_title>
	<detailed_description />
	<criteria>1 . Patients neurological disorder cause blood vessel occlusion associate acute cerebral infarction 2 . Patients receive treatment within 8 hour onset symptom acute cerebral infarction 3 . Patients intravenous administration tPA indicate reperfusion achieve intravenous tPA administration 4 . Patients accessible occlusion middle cerebral artery ( M1 M2 3 ) , basilar artery , vertebral artery , posterior cerebral artery ( P1 P2 ) , anterior cerebral artery ( A1 2 ) , intracranial internal carotid artery ( preprocedure TICI score , 0 1 ) determine angiography 5 . Patients NIHSS score 8 30 6 . Patients mRS score 0 2 onset 7 . Patients age 20 85 year ( time inform consent ) 8 . Patients able provide write consent ( signature ) whose legally acceptable representative ( person parental authority , spouse , guardian , individual legally responsible his/her custody ) provide write consent ( signature ) 1 . Patients manifest follow : Carotid artery dissection Vasculitis An angulated vessel , make difficult guide investigational device Significant ( &gt; 50 % ) stenosis , make difficult guide investigational device Acute intracranial hemorrhage Mass lesion intracranial tumor Widespread early ischemic change reveal CT MRI 2 . Patients two different major cerebrovascular occlusion require treatment 3 . Patients allergy contrast agent receive serious metal allergy 4 . Patients receive heparin within 48 hour Partial Thromboplastin Time ( PTT ) /Activated Partial Thromboplastin Time ( APTT ) &gt; twice upper limit normal 5 . Patients know bleed tendency coagulation deficiency receive oral anticoagulant ( warfarin ) , ( PT ) International Normalized Ratio ( INR ) &gt; 3 6 . Patients platelet count &lt; 30,000 /mm3 7 . Patients blood glucose level &lt; 50 mg/dL 8 . Patients uncontrolled hypertension ( systolic BP &gt; 185 mmHg diastolic BP &gt; 110 mmHg ) 9 . Patients expect life expectancy &lt; 90 day 10 . Female patient pregnant breast feed 11 . Patients participate clinical trial drug medical device 12 . Patients disqualified participation study investigator ( subinvestigator ) due reason</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>